Clinical Trials Logo

Placenta Percreta clinical trials

View clinical trials related to Placenta Percreta.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT02784886 Active, not recruiting - Placenta Accreta Clinical Trials

Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta

DNA-Accreta
Start date: November 2013
Phase: N/A
Study type: Observational

The purpose of this study is to determine whether, in a high risk population (placenta praevia and previous caesarean or prenatal suspicion of morbidly adherent placenta (MAP)), the concentration of cell-free fetal DNA circulating in the maternal plasma is significantly increased in the subgroup of morbidly adherent placenta (MAP) cases , in order to determine if the dosage of cell-free fetal DNA circulating in the maternal plasma may be a useful biological tool to detect MAP, alone or in addition to the imagery findings (ultrasonography and RMI).